SUBJECT TO COMPLETION, DATED MARCH 19, 2021
PRELIMINARY PROSPECTUS
$300,000,000
Chain Bridge I
30,000,000 Units
Chain Bridge I is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. We have not selected any business combination partner and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination partner.
This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. The underwriters have a 45-day option from the date of this prospectus to purchase up to 4,500,000 additional units to cover over-allotments, if any.
We will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination, subject to the limitations as described herein. If we do not consummate an initial business combination within 24 months from the closing of this offering, we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as described herein.
Our sponsor, Chain Bridge Group, and CB Co-Investment, L.L.C. (an affiliate of one of the underwriters in this offering) (“CB Co-Investment”) have agreed to purchase an aggregate of 5,600,000 warrants (or 6,200,000 warrants if the underwriters’ over-allotment option is exercised in full), at a price of $1.50 per warrant, in a private placement to occur concurrently with the closing of this offering for an aggregate purchase price of $8,400,000 (or $9,300,000 if the over-allotment option is exercised in full) that will close simultaneously with the closing of this offering. Among the private placement warrants, 4,266,667 warrants (or 4,716,667 warrants if the over-allotment option is exercised in full) will be purchased by our sponsor and/or its designees and 1,333,333 warrants (or 1,483,333 warrants if the over-allotment option is exercised in full) will be purchased by CB Co-Investment and/or its designees. Each private warrant is identical to the public warrants sold in this offering, subject to certain limited exceptions as described in this prospectus.
Our initial shareholders, including our sponsor and CB Co-Investment, currently own an aggregate of 8,625,000 Class B ordinary shares (up to 1,125,000 of which are subject to forfeiture if the over-allotment option is not exercised in full) which will automatically convert into Class A ordinary shares at the time of our initial business combination as described herein. Our sponsor owns 7,195,714 Class B ordinary shares (up to 938,571 of which are subject to forfeiture if the over-allotment option is not exercised in full) and CB Co-Investment owns 1,429,286 Class B ordinary shares (up to 186,429 of which are subject to forfeiture if the over-allotment option is not exercised in full). Prior to the completion of our initial business combination, only holders of our Class B ordinary shares will be entitled to vote on the appointment of directors.
Currently, there is no public market for our securities. We intend to apply to have our units listed on the Nasdaq Capital Market, or Nasdaq, under the symbol “CBRGU”. We cannot guarantee that our securities will be approved for listing on Nasdaq. We expect that the Class A ordinary shares and warrants comprising the units to begin separate trading on Nasdaq under the symbols “CBRG” and “CBRGW”, respectively on the 52nd day following the date of this prospectus unless Cowen and Company, LLC, and Wells Fargo Securities, LLC inform us of their decision to permit earlier separate trading and we have satisfied certain conditions described herein.
We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and, as such, will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 38 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings. Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | Per Unit | | | Total | |
Public offering price | | | | $ | 10.00 | | | | | $ | 300,000,000 | | |
Underwriting discounts and commissions(1) | | | | $ | 0.20 | | | | | $ | 6,000,000 | | |
Proceeds, before expenses, to us | | | | $ | 9.80 | | | | | $ | 294,000,000 | | |
(1)
The underwriters will receive compensation in addition to the underwriting discount. See also “Underwriting (Conflicts of Interest)” for a description of compensation and other items of value payable to the underwriters.
Of the proceeds we receive from this offering and the sale of the private placement warrants described in this prospectus, $300,000,000, or $345,000,000 if the underwriters’ over-allotment option is exercised in full ($10.00 per unit in either case), will be deposited into a U.S. based trust account with Continental Stock Transfer & Trust Company acting as trustee.
The underwriters are offering the units for sale on a firm commitment basis. The underwriter expects to deliver the units to the purchasers on or about , 2021.
Joint Book Running Managers
CowenWells Fargo Securities